Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Mucositis

Transdermal fentanyl in HSCT patients: an open trial using transdermal fentanyl for the treatment of oral mucositis pain

Summary:

Fentanyl is a synthetic opioid that can be delivered through a transdermal therapeutic system (TTS). The aim of this study was to assess the efficacy of fentanyl TTS in treating oral mucositis pain in 75 adult hematopoietic stem cell transplant (HSCT) patients. The analysis was based on 62 patients who developed mucositis. Pain control was assessed by the patients using a visual analogue scale (VAS) from day 0 to day +33 after HSCT. Fentanyl TTS was administered at the patient's request. In all, 20 patients did not require fentanyl (group A). The first 22 patients asking for the patch received fentanyl 25 μg/h (group B) and the subsequent 20 patients received 50 μg/h (group C). There were no significant differences in pain relief between groups B and C. The expected effect of a decrease in mean pain score (mean of the VAS scores of all of the patients in the same group each day) following the application of fentanyl TTS was not noted. We can conclude that fentanyl TTS at the doses used in this study may not adequately relieve oral mucositis pain.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Eisen D, Essell J, Broun ER . Oral cavity complications of bone marrow transplantation. Semin Cutan Med Surg 1997; 16: 265–272.

    Article  CAS  Google Scholar 

  2. Pillitteri LC, Clark RE . Comparison of a patient-controlled analgesia system with continuous infusion for administration of diamorphine for mucositis. Bone Marrow Transplant 1998; 22: 495–498.

    Article  CAS  Google Scholar 

  3. Jeal W, Benfield P . Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control. Drugs 1997; 53: 109–138.

    Article  CAS  Google Scholar 

  4. Donner B, Zenz M, Tryba M, Strumpf M . Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. Pain 1996; 64: 527–534.

    Article  CAS  Google Scholar 

  5. Gourlay GK . Treatment of cancer pain with transdermal fentanyl. Lancet Oncol 2001; 2: 165–172.

    Article  CAS  Google Scholar 

  6. Grond S, Zech D, Lehmann KA et al. Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region. Pain 1997; 69: 191–198.

    Article  CAS  Google Scholar 

  7. Donner B, Zenz M, Strumpf M, Raber M . Long-term treatment of cancer pain with transdermal fentanyl. J Pain Symptom Manage 1998; 15: 168–175.

    Article  CAS  Google Scholar 

  8. Sloan PA, Moulin DE, Hays H . A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain. J Pain Symptom Manage 1998; 16: 102–111.

    Article  CAS  Google Scholar 

  9. Allan L, Hays H, Jensen NH et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001; 322: 1154–1158.

    Article  CAS  Google Scholar 

  10. Parulekar W, Mackenzie R, Bjarnason G, Jordan RC . Scoring oral mucositis. Oral Oncol 1998; 34: 63–71.

    Article  CAS  Google Scholar 

  11. Scott J, Huskisson EC . Graphic representation of pain. Pain 1976; 2: 175–184.

    Article  CAS  Google Scholar 

  12. Demarosi F, Soligo D, Lodi G et al. Prospective evaluation of transdermal fentanyl in symptomatic treatment of oral mucositis in patients undergoing bone marrow transplantation. Bone Marrow Transplant 2003; 31 (Suppl.): 220 (abstr. 752).

    Google Scholar 

  13. Strupp C, Sudhoff T, Germing U et al. Transdermal fentanyl during high-dose chemotherapy and autologous stem cell support. Oncol Rep 2000; 7: 659–661.

    CAS  PubMed  Google Scholar 

  14. Chapman CR, Donaldson GW, Jacobson RC, Hautman B . Differences among patients in opioid self-administration during bone marrow transplantation. Pain 1997; 71: 213–223.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F Demarosi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Demarosi, F., Lodi, G., Soligo, D. et al. Transdermal fentanyl in HSCT patients: an open trial using transdermal fentanyl for the treatment of oral mucositis pain. Bone Marrow Transplant 33, 1247–1251 (2004). https://doi.org/10.1038/sj.bmt.1704515

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704515

Keywords

This article is cited by

Search

Quick links